Find A Physician
More on Americans Encouraged to Make Many Lifestyle Changes, Not Just One, to Reduce Cardiovascular Risk
Hospital News
More on Americans Encouraged to Make Many Lifestyle Changes, Not Just One, to Reduce Cardiovascular Risk
- "Bad" Cholesterol May Not Be the Best Predictor of Heart Disease Risk in Generally Healthy Individuals
- 9/11 Lifestyle Changes May Increase Cardiovascular Risk
- Columbia Research Suggests Need to Rethink Causes of Heart Failure
- Columbia Scientists Study Advantages of Using Web to Tailor Medical Information to Patients
- Comprehensive Review Finds Job Stress Does Not Contribute to Chronic High Blood Pressure
- Dean Antonio M. Gotto, Jr., Elected Fellow of American Academy of Arts and Sciences
- Diabetics Benefit Less from Anti-Hypertensive Treatment to Reduce Enlarged Heart
- Dr. Antonio M. Gotto and Dr. Herbert Pardes Awarded Austrian Cross of Honor for Science and Art
- Electrocardiogram Helps Predict Risk for Congestive Heart Failure in Hypertensive Patients
- For High-Blood-Pressure Patients, Preventing or Reducing Enlarged Heart Decreases Risk of Heart Failure
- For High Blood Pressure Patients, Preventing or Reducing Enlarged Heart May Decrease Risk for Diabetes
- From Ancient Egypt to the Science Lab to Your Dinner Plate... Garlic: It's Good for You!
- Genetic Medicine Program at Weill Cornell Receives Major Boost from The Starr Foundation
- Health Effects of Secondhand Smoke Studied in First-of-Its-Kind Series of Clinical Studies
- Heart Health Inspiration & Strategies for the Whole Family
- Hot Flashes in Women Linked to High Blood Pressure, According to New Weill Cornell Study
- How to Avoid Holiday and Winter Weight Gain
- Is Garlic Good for Your Heart? A Review of the Evidence
- JAMA Article Looks at Data-Sharing in Clinical Trials for Heart Disease
- Job Strain Linked to High Blood Pressure, Heart Disease Risk
- Larger Waistline Is Linked to Increased Risk for Heart Disease in Women
- Lovastatin Treatment Reduces Events in Patients at Varying Degrees of Coronary Risk and Reduces Need for Invasive Procedures
- Merry Stressmas
- Message to the Elderly: It's Never Too Late to Prevent Illness!
- New Laser Technology Offers Promise for Heart Disease Patients
- NewYork-Presbyterian/Columbia Announces State-of-the-Art, Vivian and Seymour Milstein Family Heart Center in Washington Heights
- NewYork-Presbyterian Receives Highest Accreditation for Bariatric Surgery
- Oh, My Aching Back! Tips on Avoiding Back Injury From NewYork-Presbyterian's Spine Center
- Reducing Enlarged Heart Muscle Cuts Patients' Cardiac Risk, Independent of Lowered Blood Pressure, NewYork-Presbyterian/Weill Cornell Researchers Report
- Researcher Predicts Paradigm Shift in Heart Disease Treatment
- Research Shows Cholesterol-Lowering Drug Lovastatin Reduces Risk of Heart Attack in Healthy Adults
- Scientific Evidence Points to Male Biological Clock
- Surgeons Who Helped Pioneer Revolutionary Technique Present International Course on NOTES Surgery
- The Mind/Body Link in Essential Hypertension: Time for a New Paradigm
- The Ties That Bind Us Can Also Heal Us
- Weill Cornell Dean and Cardiovascular Expert Makes "Top Ten" Texas List
- Weill Cornell Physician-Scientists Win 2 Top Awards at American Heart Association Meeting
- Weill Cornell Receives $7.6 Million Federal Grant for Clinical Trials on New Ways To Change Behavior in Patients With Cardiopulmonary Disease
- Weill Cornell Researcher Shows How Progesterone Is Not Just Sex Hormone but Blood Pressure Hormone
- Weill Cornell Researchers Identify a Likely Genetic Cause of Atherosclerosis
Research and Clinical Trials
More on Americans Encouraged to Make Many Lifestyle Changes, Not Just One, to Reduce Cardiovascular Risk
Health Library
More on Americans Encouraged to Make Many Lifestyle Changes, Not Just One, to Reduce Cardiovascular Risk
Clinical Services
More on Americans Encouraged to Make Many Lifestyle Changes, Not Just One, to Reduce Cardiovascular Risk
- Advanced Diagnostics
- Alcohol Septal Ablation
- Angiograms
- Angioplasty and Stenting
- Artificial Heart Devices: LVAD
- Cardiac Magnetic Resonance Imaging (MRI)
- Cardiac Rehabilitation
- Cardiology
- Cardiothoracic Surgery
- Coronary Artery Bypass Surgery (Grafting)
- Echocardiograms
- Electrocardiograms (ECGs), Stress Tests, Holter Monitor and Event/Loop Recorders
- Heart Transplant Surgery
- Intravascular / Intracoronary and Intracardiac Ultrasound
- Nuclear Imaging For Heart Disease (PET scans, MUGA scans)
- Off-pump Surgery
- Pediatric Heart Surgery
- Preventive Cardiology
- Preventive Medicine and Nutrition
- Public Health
- Robotic Heart Surgery
- Surgery for Adult Congenital Heart Disease
- The Corporate Care System
- Transmyocardial Revascularization
- Treatment of Peripheral Arterial Disease
Americans Encouraged to Make Many Lifestyle Changes, Not Just One, to Reduce Cardiovascular Risk
NEW YORK (Apr 27, 2006)
Cardiovascular disease (CVD), or disease of the heart and blood vessels, continues to be a leading killer of men and women in the United States, accounting for close to 30 percent of all deaths annually. According to a leading researcher, CVD will remain a major cause of death unless Americans make a concerted effort to manage all of their risks.
"It's going to take a lot more than one small lifestyle change to reduce the toll of cardiovascular disease significantly," said Antonio M. Gotto Jr., MD, DPhil, dean and professor of medicine at the Weill Medical College of Cornell University in New York. "Although patients can't control their age, race and genetics, they can make positive changes that will affect their blood pressure, cholesterol levels, risk for diabetes, and weight, all of which contribute to cardiovascular disease."
Dr. Gotto spoke today at an American Medical Association media briefing, Cardiovascular Disease, in New York City.
Redefining Risk
The risks patients must consider and manage today differ substantially from the risks their parents and grandparents had to consider, said Dr. Gotto. At one time, cigarette smoking was a common practice and people were not as conscious of diet and exercise.
"Over the last 20 years, even the defining levels of cardiovascular risk factors have changed," explained Dr. Gotto. "We used to believe that an LDL, or bad cholesterol, level over 160 was too high, then it changed to 130 and then 100, as more clinical evidence became available. Now, based on the data, patients at very high risk for disease may need to keep their LDL under 70."
The same is true for high blood pressure. An "optimal" level was once considered less than 120/80 mm Hg. Now that same goal is considered "normal." A systolic blood pressure in the range of 120-140 mm Hg is now considered "pre-hypertension," a warning of blood pressure issues to come.
And the worldwide challenge of cardiovascular diseases is only likely to grow in the future. "As changes occur in the developing world, we're faced with an entirely new set of issues to combat in relation to cardiovascular disease, such as obesity and diabetes," Dr. Gotto added.
Management of all Risks
"The more risk factors someone has, the more likely he or she is to have cardiovascular disease," explained Dr. Gotto. "Having multiple risk factors exponentially increases your risk for having a heart attack or stroke. In cases where patients have two or more risk factors, the heart disease risk caused by the whole package is much worse than the risk associated with each individual risk factor."
In essence, this theory can also apply to prevention and management of risk factors; the more risk factors managed, the greater chance a patient can prevent heart disease.
"Research into risk has been extremely beneficial in giving physicians a better understanding of how they can help their patients," said Dr. Gotto. "The Diabetes Prevention Program demonstrated that several lifestyle changes, such as diet and exercise, can help prevent diabetes. But other studies, such as the Women's Health Initiative, suggest that making only one change, in this case a low-fat diet, isn't enough."
"Diet and exercise will only be effective if people also lower their blood pressure and cholesterol," he said. "Without management of all the issues related to one's cardiovascular health, it is very unlikely patients will reduce risk substantially and prevent disease."
Editor's Note: Dr. Gotto serves as a consultant for AstraZeneca Pharmaceuticals, Bristol Myers Squibb, Johnson & Johnson Merck, KOS Pharmaceuticals, KOWA, Merck, Merck/Schering-Plough, Novartis, Pfizer, and Reliant. He sits on the Board of Directors for Medtronic. Dr. Gotto has received an honorarium from the American Medical Association to speak at today's conference.Contact
- Kathleen Robinson
- krobinso@med.cornell.edu